BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 16867217)

  • 1. p53-induced apoptosis occurs in the absence of p14(ARF) in malignant pleural mesothelioma.
    Hopkins-Donaldson S; Belyanskaya LL; Simões-Wüst AP; Sigrist B; Kurtz S; Zangemeister-Wittke U; Stahel R
    Neoplasia; 2006 Jul; 8(7):551-9. PubMed ID: 16867217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p14(ARF) modulates the cytolytic effect of ONYX-015 in mesothelioma cells with wild-type p53.
    Yang CT; You L; Uematsu K; Yeh CC; McCormick F; Jablons DM
    Cancer Res; 2001 Aug; 61(16):5959-63. PubMed ID: 11507034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenovirus-mediated overexpression of p14(ARF) induces p53 and Bax-independent apoptosis.
    Hemmati PG; Gillissen B; von Haefen C; Wendt J; Stärck L; Güner D; Dörken B; Daniel PT
    Oncogene; 2002 May; 21(20):3149-61. PubMed ID: 12082630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MDM2 is an important prognostic and predictive factor for platin-pemetrexed therapy in malignant pleural mesotheliomas and deregulation of P14/ARF (encoded by CDKN2A) seems to contribute to an MDM2-driven inactivation of P53.
    Walter RF; Mairinger FD; Ting S; Vollbrecht C; Mairinger T; Theegarten D; Christoph DC; Schmid KW; Wohlschlaeger J
    Br J Cancer; 2015 Mar; 112(5):883-90. PubMed ID: 25668009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azidothymidine and cisplatin increase p14ARF expression in OVCAR-3 ovarian cancer cell line.
    Vaskivuo L; Rysä J; Koivuperä J; Myllynen P; Vaskivuo T; Chvalova K; Serpi R; Savolainen ER; Puistola U; Vähäkangas K
    Toxicol Appl Pharmacol; 2006 Oct; 216(1):89-97. PubMed ID: 16797627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cooperative effect of p21Cip1/WAF-1 and 14-3-3sigma on cell cycle arrest and apoptosis induction by p14ARF.
    Hemmati PG; Normand G; Gillissen B; Wendt J; Dörken B; Daniel PT
    Oncogene; 2008 Dec; 27(53):6707-19. PubMed ID: 18806827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulated p53 expression activates apoptotic pathways in wild-type p53-bearing mesothelioma and enhances cytotoxicity of cisplatin and pemetrexed.
    Li Q; Kawamura K; Yamanaka M; Okamoto S; Yang S; Yamauchi S; Fukamachi T; Kobayashi H; Tada Y; Takiguchi Y; Tatsumi K; Shimada H; Hiroshima K; Tagawa M
    Cancer Gene Ther; 2012 Mar; 19(3):218-28. PubMed ID: 22223137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human p14(ARF)-mediated cell cycle arrest strictly depends on intact p53 signaling pathways.
    Weber HO; Samuel T; Rauch P; Funk JO
    Oncogene; 2002 May; 21(20):3207-12. PubMed ID: 12082636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant expression of cell cycle regulatory genes predicts overall and disease free survival in malignant pleural mesothelioma patients.
    Bahnassy AA; Zekri AR; Abou-Bakr AA; El-Deftar MM; El-Bastawisy A; Sakr MA; El-Sherif GM; Gaafar RM
    Exp Mol Pathol; 2012 Aug; 93(1):154-61. PubMed ID: 22504106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of p21 disrupts p14 ARF-induced G1 cell cycle arrest but augments p14 ARF-induced apoptosis in human carcinoma cells.
    Hemmati PG; Normand G; Verdoodt B; von Haefen C; Hasenjäger A; Güner D; Wendt J; Dörken B; Daniel PT
    Oncogene; 2005 Jun; 24(25):4114-28. PubMed ID: 15750619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. INK4a-ARF alterations and p53 mutations in hepatocellular carcinomas.
    Tannapfel A; Busse C; Weinans L; Benicke M; Katalinic A; Geissler F; Hauss J; Wittekind C
    Oncogene; 2001 Oct; 20(48):7104-9. PubMed ID: 11704835
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression of proteins in p53 (p14ARF-mdm2-p53-p21WAF/CIP1) pathway and their significance in exocrine pancreatic carcinoma].
    Yu GZ; Zhu MH; Ni CR; Li FM; Zheng JM; Gong ZJ
    Zhonghua Bing Li Xue Za Zhi; 2004 Apr; 33(2):130-4. PubMed ID: 15132849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus-mediated p14(ARF) gene transfer in human mesothelioma cells.
    Yang CT; You L; Yeh CC; Chang JW; Zhang F; McCormick F; Jablons DM
    J Natl Cancer Inst; 2000 Apr; 92(8):636-41. PubMed ID: 10772681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antisense to SV40 early gene region induces growth arrest and apoptosis in T-antigen-positive human pleural mesothelioma cells.
    Waheed I; Guo ZS; Chen GA; Weiser TS; Nguyen DM; Schrump DS
    Cancer Res; 1999 Dec; 59(24):6068-73. PubMed ID: 10626792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Taurolidine and povidone-iodine induce different types of cell death in malignant pleural mesothelioma.
    Opitz I; Sigrist B; Hillinger S; Lardinois D; Stahel R; Weder W; Hopkins-Donaldson S
    Lung Cancer; 2007 Jun; 56(3):327-36. PubMed ID: 17383050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptosis induced by adenovirus-mediated p14ARF expression in U2OS osteosarcoma cells is associated with increased Fas expression.
    Kim M; Sgagias M; Deng X; Jung YJ; Rikiyama T; Lee K; Ouellette M; Cowan K
    Biochem Biophys Res Commun; 2004 Jul; 320(1):138-44. PubMed ID: 15207713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bak functionally complements for loss of Bax during p14ARF-induced mitochondrial apoptosis in human cancer cells.
    Hemmati PG; Güner D; Gillissen B; Wendt J; von Haefen C; Chinnadurai G; Dörken B; Daniel PT
    Oncogene; 2006 Oct; 25(50):6582-94. PubMed ID: 16847458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of apoptosis in human esophageal cancer cells by sequential transfer of the wild-type p53 and E2F-1 genes: involvement of p53 accumulation via ARF-mediated MDM2 down-regulation.
    Itoshima T; Fujiwara T; Waku T; Shao J; Kataoka M; Yarbrough WG; Liu TJ; Roth JA; Tanaka N; Kodama M
    Clin Cancer Res; 2000 Jul; 6(7):2851-9. PubMed ID: 10914734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic alterations of INK4alpha/ARF locus and p53 in human hepatocellular carcinoma.
    Peng CY; Chen TC; Hung SP; Chen MF; Yeh CT; Tsai SL; Chu CM; Liaw YF
    Anticancer Res; 2002; 22(2B):1265-71. PubMed ID: 12168936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p14ARF expression increases dihydrofolate reductase degradation and paradoxically results in resistance to folate antagonists in cells with nonfunctional p53.
    Magro PG; Russo AJ; Li WW; Banerjee D; Bertino JR
    Cancer Res; 2004 Jun; 64(12):4338-45. PubMed ID: 15205349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.